Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02800512 · ClinicalTrials.gov registry record · NA
SCP vs HUSLS for Pelvic Organ Prolapse Repair
A NA study of Pelvic Organ Prolapse and Cystocele, sponsored by Loma Linda University.
- Active
- Registry status
- NA
- Development phase
- 112
- Enrollment target
- 1
- Study location
NCT02800512: Active NA study of Pelvic Organ Prolapse and Cystocele, sponsored by Loma Linda University.
NCT02800512 is a NA study of Pelvic Organ Prolapse and Cystocele that is active but no longer recruiting, run by Loma Linda University. The registered enrollment target is 112 participants, below the 142-participant average among 40 other Pelvic Organ Prolapse trials with a reported enrollment target (21% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02800512, a NA study of Pelvic Organ Prolapse and Cystocele, is active but no longer recruiting, sponsored by Loma Linda University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 112 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare the effectiveness of R-SCP versus HUSLS for treatment of pelvic organ prolapse.
Primary Outcome
Pelvic organ prolapses are graded with the Pelvic Organ Prolapse Quantification (POP-Q) System.
Conditions Studied
Interventions
- PROCEDURE Robotic sacrocolpopexy
- PROCEDURE high uterosacral ligament suspension
Study Locations (1)
California
- Loma Linda University URO/GYN - Loma Linda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 112 participants |
| Start Date | 2016-12 |
| Est. Completion | 2025-12 |
| Phase | NA |
What the registry record for NCT02800512 still lists
NCT02800512 is an interventional study that assigns participants to a tested intervention. The registered 112 participants enrollment target is mid-sized for trials with a published cap, below the 142-participant average among 40 other Pelvic Organ Prolapse trials with a reported enrollment target (21% lower).
The record links to 4 conditions, with Pelvic Organ Prolapse appearing as the primary indexed condition, and to 2 interventions - of which Robotic sacrocolpopexy is the first listed.
NCT02800512 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT02800512 about?
NCT02800512 is a clinical study titled "SCP vs HUSLS for Pelvic Organ Prolapse Repair". The purpose of this study is to compare the effectiveness of R-SCP versus HUSLS for treatment of pelvic organ prolapse.
What is the current status of trial NCT02800512?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 112 participants. The study started on 2016-12. Estimated completion is 2025-12.
What conditions does trial NCT02800512 study?
This clinical trial studies the following conditions: Pelvic Organ Prolapse, Cystocele, Rectocele, Enterocele.
What interventions are being tested in trial NCT02800512?
The interventions under investigation include: Robotic sacrocolpopexy (PROCEDURE), high uterosacral ligament suspension (PROCEDURE).
Who is sponsoring clinical trial NCT02800512?
This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02800512 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pelvic Organ Prolapse
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02800512's enrollment target sits among peer trials
112 15th of 40 higher than 25 of 40 other Pelvic Organ Prolapse trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pelvic Organ Prolapse trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
SORE Study: Sitz Baths After Urogynecologic Reconstruction
RECRUITING · NA
-
POMEGRANATE Trial: Comparing Reia Pessary Versus Standard of Care Pessary for Pelvic Organ Prolapse Treatment
RECRUITING · NA
-
Sequence of Midurethral Sling Placement During Robotic Sacrocolpopexy
RECRUITING · NA
-
The AccelERate Trial
RECRUITING · NA
-
Platelet Rich Plasma as an Adjunct Therapy at the Time of Transvaginal Native Tissue Prolapse Surgery
ACTIVE NOT RECRUITING · NA
-
Cranberry Tablets Versus Nitrofurantoin Prophylaxis for Urinary Tract Infection Prevention After Urogynecologic Surgery
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04511013 · 112 participants · Phase 2
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
- NCT04551560 · 112 participants · NA
Stress and Congestive Heart Failure
- NCT04872166 · 112 participants · Phase 1
A Study of BTX-A51 in People With Advanced Solid Tumor and Breast Cancer
- NCT05024773 · 112 participants · Phase 3
Study of ONCOFID-P-B (PACLITAXEL-HYALURONIC ACID)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia